Influenza immunization of pregnant women in resource-constrained countries: An update for funding and implementation decisions

Current Opinion in Infectious Diseases

Volumn 30, Issue 5, 2017, Pages 455-462

  Ortiz, Justin R ^a   Neuzil, Kathleen M ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

global health; influenza vaccine; low income and middle income countries; maternal and child health; pregnancy

Indexed keywords

INFLUENZA VACCINE;

CLINICAL DECISION MAKING; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNDING; GLOBAL DISEASE BURDEN; HEALTH CARE COST; HEALTH CARE PLANNING; HUMAN; INFLUENZA; INFLUENZA VACCINATION; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; PREGNANT WOMAN; PREVENTIVE MEDICINE; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); VACCINATION REACTION; DEVELOPING COUNTRY; NEWBORN; PANDEMIC; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL CARE; PREVENTIVE HEALTH SERVICE; VACCINATION;

DEVELOPING COUNTRIES; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; VACCINATION;

EID: 85029005806     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000392     Document Type: Review

References (65)

1. Ortiz JR, Englund JA, Neuzil KM. Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions. Vaccine 2011; 29:4439-4452.
2. World Health Organization. Vaccines against influenza WHO position paper-November 2012. Wkly Epidemiol Rec 2012; 87:461-476.
3. Adegbola R, Nesin M, Wairagkar N. Immunogenicity and efficacy of influenza immunization during pregnancy: recent and ongoing studies. Am J Obstet Gynecol 2012; 207(3 Suppl):S28-S32.
4. Madhi SA, Cutland CL, Kuwanda L, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014; 371:918-931.
5. Tapia MD, Sow SO, Tamboura B, et al. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial. Lancet Infect Dis 2016; 16:1026-1035.
6. Omer SB, Richards JL, Madhi SA, et al. Three randomized trials of maternal influenza immunization in Mali, Nepal, and South Africa: methods and expectations. Vaccine 2015; 33:3801-3812.
7. Steinhoff MC, Katz J, Englund JA, et al. Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial. Lancet Infect Dis 2017; pii: S1473-3099(17)30252-9. [Epub ahead of print]
8. Lambach P, Hombach J, Ortiz JR. A global perspective of maternal influenza immunization. Vaccine 2015; 33:6376-6379.
9. Bonhoeffer J, Kochhar S, Hirschfeld S, et al. Global alignment of immunization safety assessment in pregnancy-The GAIA project. Vaccine 2016; 34:5993-5997.
10. WorldHealthOrganization.Maternalimmunizationresearchandimplementation portfolio. Available at: http://www.who.int/immunization/research/maternal- immunization/en/. Accessed 20 March 2017.
11. World Health Organization. Meeting of the Strategic Advisory Group of Experts on immunization, April 2015: conclusions and recommendations. Wkly Epidemiol Rec 2015; 90:261-278.
12. Palache A, Oriol-Mathieu V, Fino M, Xydia-Charmanta M. Seasonal influenza vaccine dose distribution in 195 countries. Little progress in estimated global vaccination coverage. Vaccine 2015; 33:5598-5605.
13. Ortiz JR, Perut M, Dumolard L, et al. A global review of national influenza immunization policies: analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization. Vaccine 2016; 34:5400-5405.
14. Global Alliance for Vaccines, Immunisation (GAVI). Final Vaccine Investment Strategy Analysis 2013: Maternal Influenza. Geneva, Switzerland: Global Alliance for Vaccines and Immunisation (GAVI); 2013.
15. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359:1555-1564.
16. ClinicalTrials.gov. Mother's Gift Project. Available at: https://clinicaltrials.gov/ct2/show/NCT00142389. Accessed 10 April 2017.
17. Mertz D, Geraci J, Winkup J, et al. Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and metaanalysis of observational studies. Vaccine 2017; 35:521-528.
18. Katz MA, Gessner BD, Johnson J, et al. Incidence of influenza virus infection among pregnant women: a systematic review. BMC Pregnancy Childbirth 2017; 17:155.
19. Fell DB, Johnson J, Mor Z, et al. Incidence of influenza disease among infants under six months of age: a systematic review. BMJ Open 2017. In press.
20. Fell DB, Savitz DA, Kramer MS, et al. Maternal influenza and birth outcomes: systematic review of comparative studies. BJOG 2017; 124:48-59.
21. Abadom TR, Smith AD, Tempia S, et al. Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: a case-population study. Vaccine 2016; 34:5649-5655.
22. Tempia S, Walaza S, Cohen AL, et al. Mortality associated with seasonal and pandemic influenza among pregnant and nonpregnant women of childbearing age in a high-HIV-prevalence setting-South Africa. Clin Infect Dis 2015; 61:1063-1070.
23. Cohen C, Moyes J, Tempia S, et al. Epidemiology of acute lower respiratory tract infection in hiv-exposed uninfected infants. Pediatrics 2016; 137:.
24. Weinberg A, Mussi-Pinhata MM, Yu Q, et al. Excess respiratory viral infections and low antibody responses among HIV-exposed, uninfected infants. AIDS (London, England) 2017; 31:669-679.
25. Keller-Stanislawski B, Englund JA, Kang G, et al. Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. Vaccine 2014; 32:7057-7064.
26. Fell DB, Bhutta ZA, Hutcheon JA, et al. Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30-October 1. Vaccine 2017.
27. Fell DB, Platt RW, Lanes A, et al. Fetal death and preterm birth associated with maternal influenza vaccination: systematic review. BJOG 2015; 122:17-26.
28. McMillan M, Porritt K, Kralik D, et al. Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine 2015; 33:2108-2117.
29. Nunes MC, Aqil AR, Omer SB, Madhi SA. The effects of influenza vaccination during pregnancy on birth outcomes: a systematic review and meta-analysis. Am J Perinatol 2016; 33:1104-1114.
30. Hviid A, Svanstrom H, Molgaard-Nielsen D, Lambach P. Association between pandemic influenza A (H1N1) vaccination in pregnancy and early childhood morbidity in offspring. JAMA Pediatr 2017; 171:239-248.
31. Cassidy C, MacDonald NE, Steenbeek A, et al. A global survey of adverse event following immunization surveillance systems for pregnant women and their infants. Hum Vac Immunother 2016; 12:2010-2016.
32. Fulton TR, Narayanan D, Bonhoeffer J, et al. A systematic review of adverse events following immunization during pregnancy and the newborn period. Vaccine 2015; 33:6453-6465.
33. Munoz FM, Eckert LO, Katz MA, et al. Key terms for the assessment of the safety of vaccines in pregnancy: results of a global consultative process to initiate harmonization of adverse event definitions. Vaccine 2015; 33:6441-6452.
34. Jones CE, Munoz FM, Kochhar S, et al. Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy. Vaccine 2016; 34:6007-6014.
35. Jones CE, Munoz FM, Spiegel HM, et al. Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women. Vaccine 2016; 34:5998-6006.
36. De Serres G, Skowronski DM. Re: 'Detectable risks in studies of the fetal benefits of maternal influenza vaccination'. Am J Epidemiol 2017; 185:860-861.
37. Nunes MC, Cutland CL, Dighero B, et al. Kinetics of hemagglutinationinhibiting antibodies following maternal influenza vaccination among mothers with and those without HIV infection and their infants. J Infect Dis 2015; 212:1976-1987.
38. Nunes MC, Cutland CL, Jones S, et al. Duration of infant protection against influenza illness conferred by maternal immunization: secondary analysis of a randomized clinical trial. JAMA Pediatr 2016; 170:840-847.
39. Nunes MC, Cutland CL, Jones S, et al. Efficacy of maternal influenza vaccination against all-cause lower respiratory tract infection hospitalizations in young infants: results from a randomized controlled trial. Clin Infect Dis 2017. [Epub ahead of print]
40. de Francisco Shapovalova N, Donadel M, Jit M, Hutubessy R. A systematic review of the social and economic burden of influenza in low-and middleincome countries. Vaccine 2015; 33:6537-6544.
41. Ott JJ, Klein Breteler J, Tam JS, et al. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations. Hum Vac Immunother 2013; 9:1500-1511.
42. World Health Organization. Guidance on the economic evaluation of influenza vaccination. Available at: http://apps.who.int/iris/bitstream/10665/250086/1/WHO-IVB-16.05-eng.pdf. Accessed 10 April 2017.
43. World Health Organization. WHO Manual for estimating the economic burden of seasonal influenza. Available at: http://apps.who.int/iris/bit stream/10665/250085/1/WHO-IVB-16.04-eng.pdf. Accessed 10 April 2017.
44. Steinhoff MC, Omer SB, Roy E, et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 2012; 184:645-653.
45. McHugh L, Andrews RM, Lambert SB, et al. Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: The FluMum study. Vaccine 2017; 35:1403-1409.
46. & Olsen SJ, Mirza SA, Vonglokham P, et al. The effect of influenza vaccination on birth outcomes in a cohort of pregnant women in Lao PDR. Clin Infect Dis 2016; 63:487-494.
47. Regan AK, Moore HC, de Klerk N, et al. Seasonal trivalent influenza vaccination during pregnancy and the incidence of stillbirth: population-based retrospective cohort study. Clin Infect Dis 2016; 62:1221-1227.
48. Savitz DA, Fell DB, Ortiz JR, Bhat N. Does influenza vaccination improve pregnancy outcome? Methodological issues and research needs. Vaccine 2015; 33:6430-6435.
49. Hutcheon JA, Savitz DA. Invited commentary: influenza, influenza immunization, and pregnancy-it's about time. Am J Epidemiol 2016; 184:187-191.
50. Vazquez-Benitez G, Kharbanda EO, Naleway AL, et al. risk of preterm or smallfor-gestational-age birth after influenza vaccination during pregnancy: caveats when conducting retrospective observational studies. Am J Epidemiol 2016; 184:176-186.
51. Hutcheon JA, Fell DB, Jackson ML, et al. Detectable risks in studies of the fetal benefits of maternal influenza vaccination. Am J Epidemiol 2016; 184:227-232.
52. Ortiz JR, Neuzil KM, Cooke CR, et al. Influenza pneumonia surveillance among hospitalized adults may underestimate the burden of severe influenza disease. PloS One 2014; 9:e113903.
53. Gessner BD, Brooks WA, Neuzil KM, et al. Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France). Vaccine 2013; 31:3222-3228.
54. Roberts JN,Gruber MF. Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy. Vaccine 2015; 33:966-972.
55. Proveaux T, Lambach P, Ortiz JR, et al. Review of prescribing information for influenza vaccines for pregnant and lactating women. Vaccine 2016; 34:5406-5409.
56. Top KA, Arkell C, Scott H, et al. Effect of package insert language on healthcare providers' perceptions of influenza vaccination safety during pregnancy. Lancet Global Health 2016; 4:e690-e691.
57. Gruber MF. The US FDA pregnancy lactation and labeling rule-implications for maternal immunization. Vaccine 2015; 33:6499-6500.
58. World Health Organization. Appendix 4. Labelling Information of Inactivated Influenza Vaccines for Use in Pregnant Women. Available at: http://www. who.int/biologicals/expert-committee/Label-after-ECBS-HK-28-Oct-2016. clean.pdf?ua=1. Accessed 9 April 2017.
59. UNICEF. Only half of women worldwide receive the recommended amount of care during pregnancy. Available at: https://data.unicef.org/topic/maternalhealth/antenatal-care/#. Accessed 10 April 2017.
60. Hodgins S, D'Agostino A. The quality-coverage gap in antenatal care: toward better measurement of effective coverage. Global Health, Sci Pract 2014; 2:173-181.
61. World Health Organization. WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience. Available at: http://apps.who.int/iris/bitstream/10665/250796/1/9789241549912-eng.pdf. Accessed 10 April 2017.
62. WorldHealthOrganization.Howto implement influenza vaccination of pregnant women: An introduction manual for nationalimmunization programmemanagers and policy makers. Available at: http://apps.who.int/iris/bitstream/10665/250084/1/WHO-IVB-16.06-eng.pdf. Accessed 10 April 2017.
63. World Health Organization. WHO Flutool for planning and costing maternal influenza vaccination. Available at: http://apps.who.int/iris/bitstream/10665/250087/1/WHO-IVB-16.07-eng.pdf. Accessed 10 April 2017.
64. Hirve S, Newman LP, Paget J, et al. Influenza seasonality in the tropics and subtropics-when to vaccinate? PloS One 2016; 11:e0153003.
65. Lambach P, Alvarez AM, Hirve S, et al. Considerations of strategies to provide influenza vaccine year round. Vaccine 2015; 33:6493-6498.